Polycythemia Vera
📧 Sign up to get email alerts when something new happens for Polycythemia Vera.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: Dasatinib in Polycythemia Vera [Phase 2]
A Phase 2 trial of dasatinib in polycythemia vera was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies [NA]
Clinical trial update for fludarabine-based conditioning prior to allogeneic transplantation in advanced hematologic malignancies; study com…
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms [Phase 1]
Phase 1 study of LY2784544 testing alternative dosing in patients with myeloproliferative neoplasms, including polycythemia vera, essential …
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation [Phase 1, Phase 2]
A Phase 1/2 clinical trial update reports completion of a study evaluating an investigational biological therapy in adults with advanced mye…
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET) [Phase 2]
A Phase 2 trial evaluating pegylated interferon alfa-2a as salvage therapy in high-risk polycythemia vera or high-risk essential thrombocyth…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-11-28Clinical Trial Update: Pegylated Interferon Alpha-2b Versus Hydroxyurea in Polycythemia Vera [Phase 3]
Phase 3 trial comparing pegylated interferon alpha-2b with hydroxyurea in polycythemia vera has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-23Clinical Trial Update: HSP90 Inhibitor, AUY922, in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF), and Refractory PV/ET [Phase 2]
Phase 2 trial of the HSP90 inhibitor AUY922 in myeloproliferative neoplasms including primary myelofibrosis and MF after PV/ET was terminate…
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Study to Assess the Self-administration of AOP2014 Using a Pen, Developed for the Treatment of Polycythemia Vera Patients [Phase 3]
Phase 3 trial update reporting completion of a study evaluating self-administration of AOP2014 via a pen for polycythemia vera.
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: Open Label Study to Evaluate the Activity of Imetelstat in Patients With Essential Thrombocythemia or Polycythemia Vera [Phase 2]
An open-label Phase 2 trial evaluating imetelstat in essential thrombocythemia or polycythemia vera has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-21Clinical Trial Update: Efficacy and Safety of Pegylated Interferon Alfa in Polycythemia Vera [Phase 2]
This update reports on the efficacy and safety outcomes of pegylated interferon alfa in polycythemia vera from a Phase 2 trial that has comp…
-
CLINICAL_TRIALS trial_result · 2015-10-08Clinical Trial Update: Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis [Phase 2]
A Phase 2 open-label trial of oral CEP-701 (lestaurtinib) in Polycythemia Vera and Essential Thrombocythemia has completed.
-
CLINICAL_TRIALS trial_result · 2015-08-21Clinical Trial Update: A Phase 1 Study of XL019 in Adults With Polycythemia Vera [Phase 1]
The Phase 1 study XL019 in adults with Polycythemia Vera has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-04-07Clinical Trial Update: Randomized Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of Polycythemia Vera Symptoms: The Relief Study [Phase 3]
Phase 3 randomized trial evaluating switching from hydroxyurea to ruxolitinib for relief of polycythemia vera symptoms; results were posted …
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: Study of Efficacy and Safety in Polycythemia Vera Subjects Who Are Resistant to or Intolerant of Hydroxyurea: JAK Inhibitor INC424 (INCB018424) Tablets Versus Best Available Care: (The RESPONSE Trial) [Phase 3]
Phase 3 study comparing a JAK inhibitor INC424 (ruxolitinib) to best available care in hydroxyurea-resistant or -intolerant polycythemia ver…
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: LBH589 (Panobinostat) for the Treatment of Myelofibrosis [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trial update for LBH589 (panobinostat) in myelofibrosis with current status not reported.
-
CLINICAL_TRIALS trial_result · 2014-10-08Clinical Trial Update: Effects of Imatinib Mesylate in Polycythemia Vera [Phase 2]
A Phase 2 study evaluating imatinib mesylate in polycythemia vera has completed, with results summarized in this update.
-
CLINICAL_TRIALS trial_result · 2014-08-28Clinical Trial Update: Anti-TGF-beta Therapy in Patients With Myelofibrosis [Phase 1]
Phase 1 trial evaluating an anti-TGF-beta therapy in myelofibrosis was terminated; results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-05-21Clinical Trial Update: 3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia [Phase 2]
Phase 2 trial evaluating the combination of Triapine (3-AP) and fludarabine in various myeloproliferative disorders and advanced phases of c…
-
CLINICAL_TRIALS trial_result · 2014-02-25Clinical Trial Update: Imatinib Mesylate in Treating Patients With Myelofibrosis [Phase 2]
Phase 2 clinical trial evaluating Imatinib Mesylate in patients with myelofibrosis has completed. The study also addresses related myeloprol…
-
CLINICAL_TRIALS trial_result · 2013-09-26Clinical Trial Update: Lenalidomide and Prednisone in Treating Patients With Myelofibrosis [Phase 2]
This Phase 2 trial evaluated lenalidomide in combination with prednisone for patients with myelofibrosis and related myeloproliferative neop…
-
CLINICAL_TRIALS trial_result · 2013-06-17Clinical Trial Update: Plasma Vitamin and Homocysteine Levels and Thrombosis in Patients With Ph-negative MPNs
This clinical trial update reports on plasma vitamin and homocysteine levels and thrombosis in patients with Philadelphia-negative myeloprol…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Tipifarnib in Treating Patients With Myelofibrosis and Myeloid Metaplasia [Phase 2]
Phase 2 clinical trial update on tipifarnib for myelofibrosis and related myeloproliferative disorders, with the study having completed.
-
CLINICAL_TRIALS trial_result · 2012-08-02Clinical Trial Update: Open Label Ruxolitinib (INCB018424) in Patients With Myelofibrosis and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis [Phase 1, Phase 2]
Open-label Phase 1/2 trial results for ruxolitinib (INCB018424) in patients with myelofibrosis, including those with post-polycythemia vera/…
-
CLINICAL_TRIALS trial_result · 2012-04-20Clinical Trial Update: A Phase 1/2 Study of Oral SB1518 in Subjects With Chronic Idiopathic Myelofibrosis [Phase 1, Phase 2]
The Phase 1/2 study of oral SB1518 (pacritinib) in chronic idiopathic myelofibrosis has completed, with the trial listing other myeloprolife…
-
CLINICAL_TRIALS trial_result · 2012-02-24Clinical Trial Update: Study to Determine the Safety and Efficacy of INCB018424 in Patients With Polycythemia Vera or Essential Thrombocythemia [Phase 2]
Phase 2 study of ruxolitinib (INCB018424) in polycythemia vera and essential thrombocythemia was terminated, with results posted in 2012.